At Genetic Future, blogger Daniel MacArthur warns readers who are thinking of buying a SNP scan from one of the three leading personal genomics companies to think twice. First, these tests gauge variation by looking at common variants, which misses the point:  disease isn't usually caused by simply one allelic mutation, but by many rare variants. Secondly, gene chips won't do the job here.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.